| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 23, 2026
Empowering endoscopists with meaningful insights
-
Feb 19, 2026
Milestone expands patient access to the first and most studied renal denervation therapy for hypertension.
-
Feb 17, 2026
Infuse™ is the only PMA-approved growth factor bone graft indicated for ALIF, OLIF, and TLIF
-
Feb 5, 2026
Medtronic in India drives awareness on Bradycardia with #DecodeYourRhythm Campaign.
-
Jan 22, 2026
University of Colorado selected as a strategic academic partner given the strength of the capabilities to advance disruptive innovation in health care
-
Jan 7, 2026
Pharmacy Benefit agreements expand portfolio coverage to simplify access for eligible customers and providers
-
Dec 11, 2025
Results from Australia, Japan and Hong Kong highlight the potential impact across healthcare systems in the Asia-Pacific region
-
Dec 10, 2025
First patient successfully treated by Ajit Rao, MD, at The Mount Sinai Hospital, NY
-
Dec 8, 2025
Onyx™ 18, 34 Liquid Embolic System offers step forward in treatment options for cSDH
-
Dec 4, 2025
Now supported with effectiveness evidence, Medtronic DBS is the first and only U.S. FDA approved system to treat Dystonia symptoms
-
Nov 14, 2025
APHRS.25: Medtronic showcases breadth of defibrillation portfolio with outcomes from extravascular and transvenous defibrillation studies for the treatment of dangerous heart rhythm episodes


